Literature DB >> 8967755

Myelin basic protein and human coronavirus 229E cross-reactive T cells in multiple sclerosis.

P J Talbot1, J S Paquette, C Ciurli, J P Antel, F Ouellet.   

Abstract

Multiple sclerosis (MS) is an inflammatory demyelinating neurological disease in which autoreactive T lymphocytes sensitized to myelin components of the central nervous system are postulated to contribute to pathogenesis. The possible relevance of molecular mimicry between a human coronavirus and the myelin basic protein component of myelin in the generation of this autoimmune reaction was evaluated. Myelin basic protein- and virus-reactive T-cell lines were established from 16 MS patients and 14 healthy donors and shown to be mostly CD4+. In contrast to healthy donors, several T-cell lines isolated from MS patients showed cross-reactivity between myelin and coronavirus antigens. Overall, 29% of T-cell lines from MS patients (10 donors) but only 1.3% of T-cell lines from normal control subjects (2 donors) showed an HLA-DR-restricted cross-reactive pattern of antigen activation after in vitro selection with either myelin basic protein or human coronavirus strain 229E antigens. Moreover, reciprocal reactivities were only observed in MS patients (4 donors). This establishes molecular mimicry between a common viral pathogen, such as this human coronavirus, and myelin as a possible immunopathological mechanism in MS and is consistent with the possible involvement of more than one infectious pathogen as an environmental trigger of disease.

Entities:  

Mesh:

Substances:

Year:  1996        PMID: 8967755      PMCID: PMC7159680          DOI: 10.1002/ana.410390213

Source DB:  PubMed          Journal:  Ann Neurol        ISSN: 0364-5134            Impact factor:   10.422


  39 in total

1.  Sequence homology between certain viral proteins and proteins related to encephalomyelitis and neuritis.

Authors:  U Jahnke; E H Fischer; E C Alvord
Journal:  Science       Date:  1985-07-19       Impact factor: 47.728

Review 2.  Tolerance, danger, and the extended family.

Authors:  P Matzinger
Journal:  Annu Rev Immunol       Date:  1994       Impact factor: 28.527

3.  T lymphocyte lines and clones selected against synthetic myelin basic protein 82-102 peptide from Japanese multiple sclerosis patients.

Authors:  J Inobe; T Yamamura; T Kunishita; T Tabira
Journal:  J Neuroimmunol       Date:  1993-07       Impact factor: 3.478

4.  Interferon beta-1b is effective in relapsing-remitting multiple sclerosis. II. MRI analysis results of a multicenter, randomized, double-blind, placebo-controlled trial. UBC MS/MRI Study Group and the IFNB Multiple Sclerosis Study Group.

Authors:  D W Paty; D K Li
Journal:  Neurology       Date:  1993-04       Impact factor: 9.910

5.  Minimum structural requirements for peptide presentation by major histocompatibility complex class II molecules: implications in induction of autoimmunity.

Authors:  A M Gautam; C B Lock; D E Smilek; C I Pearson; L Steinman; H O McDevitt
Journal:  Proc Natl Acad Sci U S A       Date:  1994-01-18       Impact factor: 11.205

6.  Human coronavirus gene expression in the brains of multiple sclerosis patients.

Authors:  J N Stewart; S Mounir; P J Talbot
Journal:  Virology       Date:  1992-11       Impact factor: 3.616

Review 7.  Molecular mimicry: a mechanism for autoimmune injury.

Authors:  L A Barnett; R S Fujinami
Journal:  FASEB J       Date:  1992-02-01       Impact factor: 5.191

8.  Human T cells respond to mouse mammary tumor virus-encoded superantigen: V beta restriction and conserved evolutionary features.

Authors:  N Labrecque; H McGrath; M Subramanyam; B T Huber; R P Sékaly
Journal:  J Exp Med       Date:  1993-06-01       Impact factor: 14.307

9.  Sequence analysis of human coronavirus 229E mRNAs 4 and 5: evidence for polymorphism and homology with myelin basic protein.

Authors:  P Jouvenne; S Mounir; J N Stewart; C D Richardson; P J Talbot
Journal:  Virus Res       Date:  1992-02       Impact factor: 3.303

10.  Influence of infection on exacerbations of multiple sclerosis.

Authors:  H S Panitch
Journal:  Ann Neurol       Date:  1994       Impact factor: 10.422

View more
  48 in total

Review 1.  Murine coronavirus infection: a paradigm for virus-induced demyelinating disease.

Authors:  T E Lane; M J Buchmeier
Journal:  Trends Microbiol       Date:  1997-01       Impact factor: 17.079

Review 2.  The critical role of antigen-presentation-induced cytokine crosstalk in the central nervous system in multiple sclerosis and experimental autoimmune encephalomyelitis.

Authors:  Rebecca A Sosa; Thomas G Forsthuber
Journal:  J Interferon Cytokine Res       Date:  2011-09-15       Impact factor: 2.607

Review 3.  Multiple Sclerosis and T Lymphocytes: An Entangled Story.

Authors:  Laurine Legroux; Nathalie Arbour
Journal:  J Neuroimmune Pharmacol       Date:  2015-05-07       Impact factor: 4.147

4.  Neuroinvasion by human respiratory coronaviruses.

Authors:  N Arbour; R Day; J Newcombe; P J Talbot
Journal:  J Virol       Date:  2000-10       Impact factor: 5.103

5.  Infection of primary cultures of human neural cells by human coronaviruses 229E and OC43.

Authors:  A Bonavia; N Arbour; V W Yong; P J Talbot
Journal:  J Virol       Date:  1997-01       Impact factor: 5.103

6.  Persistent infection of human oligodendrocytic and neuroglial cell lines by human coronavirus 229E.

Authors:  N Arbour; S Ekandé; G Côté; C Lachance; F Chagnon; M Tardieu; N R Cashman; P J Talbot
Journal:  J Virol       Date:  1999-04       Impact factor: 5.103

Review 7.  The immunopathophysiology of multiple sclerosis.

Authors:  Gregory F Wu; Enrique Alvarez
Journal:  Neurol Clin       Date:  2011-05       Impact factor: 3.806

8.  Severe acute respiratory syndrome coronavirus and viral mimicry.

Authors:  Fook Tim Chew; Su Yin Ong; Choy Leong Hew
Journal:  Lancet       Date:  2003-06-14       Impact factor: 79.321

Review 9.  The X and why of xenobiotics in primary biliary cirrhosis.

Authors:  Roman Rieger; M Eric Gershwin
Journal:  J Autoimmun       Date:  2007-03-23       Impact factor: 7.094

Review 10.  Primary biliary cirrhosis.

Authors:  Simon Hohenester; Ronald P J Oude-Elferink; Ulrich Beuers
Journal:  Semin Immunopathol       Date:  2009-07-15       Impact factor: 9.623

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.